Expertise in
4
conditions

Charles H. Marquette

Nice, FR 
Expertise in
4
conditions
Nice, FR 

Overview

Charles Marquette practices practicing medicine in Nice, France.

Marquette is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Emphysema, Exogenous Lipoid Pneumonia, Lung Cancer, Tissue Biopsy, and Endoscopy.

They are actively involved in clinical research, co-authoring 44 peer reviewed articles and participating in 3 clinical trials.

Locations

Nice, France
Other Locations
Valbonne, France
Caen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects
Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
View 2 Less Clinical Trials

44 Total Publications

Genomic landscape of stage 0-IA lung adenocarcinoma identified by on-site reflex targeted NGS.
Genomic landscape of stage 0-IA lung adenocarcinoma identified by on-site reflex targeted NGS.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 07, 2025

Frequently Asked Questions about Charles H. Marquette

Is Charles H. Marquette a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Charles H. Marquette is classified as an Distinguished expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Charles H. Marquette participate in research or clinical trials?

Yes. Charles H. Marquette has published 44 articles and abstracts on conditions like Emphysema. You can view a list of Charles H. Marquette's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Marquette's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile